Pfizer To Present ALLHAT Analysis At Advisory Committee On Antihypertensive Labeling
This article was originally published in The Pink Sheet Daily
Executive Summary
The company will present a non-inferiority analysis suggesting Norvasc (amlodipine) is similar to the diuretic chlorthalidone in preventing hypertension outcomes during a June 15 meeting of FDA's Cardiovascular & Renal Drugs Advisory Committee, the agency says.